CordenPharma and GE to cover 'any Oligo customer needs,' say companies
CordenPharma and GE Healthcare have teamed up to serve the fast growing Oligonucleotide market with complementary offerings.
CordenPharma and GE Healthcare have teamed up to serve the fast growing Oligonucleotide market with complementary offerings.
The European Medicines Agency has approved a new tablet formulation of Esbriet (pirfenidone), which Roche says reduces pill-load and increases dosing flexibility for patients with a rare lung disease.
Industry delegates say the US Food and Drug Administration (FDA) is showing increased support for continuous manufacturing, a stance C-SOPS told us is quality control-driven.
INC Research has relocated and expanded its Tokyo, Japan-based office to support the company’s growth strategy in the Asia-Pacific region.